- Home
- FXNC vs PRQR Comparison
FXNC vs PRQR Comparison
Compare FXNC & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FXNC
- PRQR
- Stock Information
- Founded
- FXNC 1907
- PRQR 2012
- Country
- FXNC United States
- PRQR Netherlands
- Employees
- FXNC N/A
- PRQR N/A
- Industry
- FXNC Major Banks
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- FXNC Finance
- PRQR Health Care
- Exchange
- FXNC Nasdaq
- PRQR Nasdaq
- Market Cap
- FXNC 203.9M
- PRQR 224.4M
- IPO Year
- FXNC N/A
- PRQR 2014
- Fundamental
- Price
- FXNC $22.30
- PRQR $3.02
- Analyst Decision
- FXNC
- PRQR Strong Buy
- Analyst Count
- FXNC 0
- PRQR 8
- Target Price
- FXNC N/A
- PRQR $8.88
- AVG Volume (30 Days)
- FXNC 14.4K
- PRQR 626.8K
- Earning Date
- FXNC 10-24-2025
- PRQR 11-06-2025
- Dividend Yield
- FXNC 2.82%
- PRQR N/A
- EPS Growth
- FXNC N/A
- PRQR N/A
- EPS
- FXNC 0.96
- PRQR N/A
- Revenue
- FXNC $71,824,000.00
- PRQR $20,129,184.00
- Revenue This Year
- FXNC $57.18
- PRQR N/A
- Revenue Next Year
- FXNC $5.15
- PRQR N/A
- P/E Ratio
- FXNC $22.92
- PRQR N/A
- Revenue Growth
- FXNC 46.30
- PRQR 8.65
- 52 Week Low
- FXNC $18.26
- PRQR $1.07
- 52 Week High
- FXNC $26.97
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- FXNC 45.54
- PRQR 71.55
- Support Level
- FXNC $21.59
- PRQR $2.60
- Resistance Level
- FXNC $22.64
- PRQR $2.58
- Average True Range (ATR)
- FXNC 0.55
- PRQR 0.23
- MACD
- FXNC -0.07
- PRQR 0.07
- Stochastic Oscillator
- FXNC 40.41
- PRQR 96.17
About FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. Key revenue is generated from Community Banking.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.